Literature DB >> 21921167

AIDS research. Novel antibody response may explain HIV vaccine success.

Jon Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21921167     DOI： 10.1126/science.333.6049.1560

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

Review 1.  Prospects for an HIV vaccine: leading B cells down the right path.

Authors:  Susan Moir; Angela Malaspina; Anthony S Fauci
Journal:  Nat Struct Mol Biol       Date:  2011-12-05       Impact factor: 15.369

2.  Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodies.

Authors:  Sanchari Bhattacharyya; Pranveer Singh; Ujjwal Rathore; Mansi Purwar; Denise Wagner; Heather Arendt; Joanne DeStefano; Celia C LaBranche; David C Montefiori; Sanjay Phogat; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

3.  Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.

Authors:  Josephine H Cox; Maria G Ferrari; Patricia Earl; James R Lane; Linda L Jagodzinski; Victoria R Polonis; Ellen G Kuta; Jean D Boyer; Silvia Ratto-Kim; Leigh-Anne Eller; Doan-Trang Pham; Lydia Hart; David Montefiori; Guido Ferrari; Stephanie Parrish; David B Weiner; Bernard Moss; Jerome H Kim; Deborah Birx; Thomas C VanCott
Journal:  Vaccine       Date:  2012-01-09       Impact factor: 3.641

4.  HIV vaccines: can CD4+ T cells be of help?

Authors:  Eva Van Braeckel; Geert Leroux-Roels
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

5.  Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.

Authors:  Raghavan Sampathkumar; Elnaz Shadabi; Ma Luo
Journal:  Adv Virol       Date:  2012-05-16

6.  Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers.

Authors:  Sanjay Mehendale; Madhuri Thakar; Seema Sahay; Makesh Kumar; Ashwini Shete; Pattabiraman Sathyamurthi; Amita Verma; Swarali Kurle; Aparna Shrotri; Jill Gilmour; Rajat Goyal; Len Dally; Eddy Sayeed; Devika Zachariah; James Ackland; Sonali Kochhar; Josephine H Cox; Jean-Louis Excler; Vasanthapuram Kumaraswami; Ramesh Paranjape; Vadakkuppatu Devasenapathi Ramanathan
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

7.  Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection.

Authors:  Xueying Fan; Liyan Zhu; Hua Liang; Zhe Xie; Xiangbo Huang; Shuo Wang; Tao Shen
Journal:  Retrovirology       Date:  2016-11-04       Impact factor: 4.602

8.  Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.

Authors:  Eric A Weaver; Pramod N Nehete; Bharti P Nehete; Guojun Yang; Stephanie J Buchl; Patrick W Hanley; Donna Palmer; David C Montefiori; Guido Ferrari; Philip Ng; K Jagannadha Sastry; Michael A Barry
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.